A systems approach to the different grades and progression of human astrocytoma

Wang, Chunjing

Permalink

https://hdl.handle.net/2142/26406 Copy

Description

Title

A systems approach to the different grades and progression of human astrocytoma

Author(s)

Wang, Chunjing

Issue Date

2011-08-26T15:34:43Z

Director of Research (if dissertation) or Advisor (if thesis)

Price, Nathan D.

Department of Study

Chemical & Biomolecular Engr

Discipline

Chemical Engineering

Degree Granting Institution

University of Illinois at Urbana-Champaign

Degree Name

M.S.

Degree Level

Thesis

Date of Ingest

2011-08-26T15:34:43Z

Keyword(s)

• Systems biology
• Human astrocytoma
• progression
• network classifier
• prognosis
• classification

Abstract

Astrocytomas are the most common glioma, accounting for about half of all primary brain and spinal cord tumors. Malignancy in these tumors ranges from the least aggressive pilocytic astrocytoma (WHO grade 1) to the most aggressive glioblastoma (WHO grade 4). Molecular biomarkers or signatures—i.e., patterns of gene or protein expression that can reliably distinguish between each grade and provide insight into the underlying molecular events associated with tumor progression—have not yet been well established for astrocytomas. To identify candidate biomarkers and characterize genetic and molecular mechanisms driving glioma development and progression, we performed a meta-analysis of publicly available microarray gene expression datasets, comprising 432 tumor samples from all four grades and 28 non-tumor samples. We first applied a consensus preprocessing method to raw microarray data to reduce bias introduced by different laboratories. Using DIRAC, a network-based classification approach previously developed in our lab, we were able to effectively differentiate tumor grades with an average accuracy of 87%. Additionally, we derived 46 specific transcriptional changes that are associated with astrocytoma progression; of the 46 genes, 27 were consistently upregulated and 19 were downregulated in the progression sequence. Notably, we discovered a histology-independent classifier, a network using erythropoietin to mediate neuroprotection through NF-kB (EPONFKB), consisting of 11 genes and predictive of survival in high grade astrocytoma (HGA) patients. This network is known for its roles in neuronal development and is capable of classifying HGAs into previously unrecognized subtypes. It has proven to be a more significant survival predictor (P = 2.4e-8) than histology-based grading (P = 2.2e-6). With our network signatures associated with each grade and our progression-associated genes, we hope to increase the understanding of molecular mechanisms leading to brain cancer development, maintenance and progression. With the identification of the EPONFKB network as a novel prognostic factor, we hope to move tumor diagnosis and prognosis toward a more quantitative realm.

Graduation Semester

2011-08

Permalink

http://hdl.handle.net/2142/26406

Copyright and License Information

Copyright 2011 Chunjing Wang

Owning Collections